Word from some home office people this week has been rumors that the company is looking to sell off the Neuroscience BU. It does not fit with the Rare Diseases focus of the company. Explains why PS was given more than just Neuroscience recently. Hopefully no one commits to moving to Lexington and then gets sold off.
